Hepatitis B core antigen is a potent inductor of interleukin-18 in peripheral blood mononuclear cells of healthy controls and patients with hepatitis B infection

Journal of Medical Virology

Volumn 71, Issue 1, 2003, Pages 31-40

  Manigold, Tobias ^a,b   Böcker, Ulrich ^a   Chen, Jingsan ^a   Gundt, Jutta ^a   Traber, Petra ^a   Singer, Manfred V ^a   Rossol, Siegbert ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

ELISA; HBcAg; HBV infection; IL 18; Quantitative RT PCR

Indexed keywords

CD40 ANTIGEN; CD40 LIGAND; GAMMA INTERFERON; HEPATITIS B CORE ANTIGEN; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 1BETA CONVERTING ENZYME;

ACUTE HEPATITIS; ADULT; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; DOSE RESPONSE; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MALE; MONONUCLEAR CELL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TH1 CELL; TRANSCRIPTION REGULATION; VIREMIA;

ADULT; FEMALE; GENE EXPRESSION REGULATION; HEPATITIS B; HEPATITIS B CORE ANTIGENS; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HUMANS; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-18; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; TRANSCRIPTION, GENETIC;

HEPATITIS B VIRUS;

EID: 0141570999     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.10445     Document Type: Article

References (47)

1. Alheim M, Lazdina U, Milich DR, Sallberg M. 2001. Flow cytometric determination of cytokine production and proliferation in hepatitis B core antigen specific murine CD4 cells: lack of correlation between number of cytokine producing cells and cytokine levels in supernatant. J Immunol Methods 258:157-167.
2. Böyum A. 1968. Separation of leukocytes from blood and bone marrow. Scand J Clin Lab Invest 21:77-89.
3. Barlet V, Zarski JP, Thelu MA, Seigneurin JM. 1991. Advantage of PCR for detecting low amounts of HBV DNA in patients' sera. Res Virol 142:373-379.
4. Bertoletti A, D'Elios MM, Boni C, De Carli M, Zignego AL, Durazzo M, Missale G, Penna A, Fiaccadori F, Del Prete G, Ferrari C. 1997. Different cytokine profiles of intraphepatic T cells in chronic hepatitis B and hepatitis C virus infections. Gastroenterology 112:193-199.
5. Böcker U, Manigold T, Watson JM, Singer MV, Rossol S. 2001. Regulation of Staphylococcus aureus-mediated activation of interleukin-18 in peripheral blood mononuclear cells. Eur Cytokine Netw 12:631-638.
6. Borisova GP, Kalis Ia V, Pushko PM, Tsibinogin VV, Loseva V. 1988. [Genetically engineered mutants of the core antigen of the human hepatitis B virus preserving the ability for native self-assembly.] Dokl Akad Nauk SSSR 298:1474-1478.
7. Carreno V, Zeuzem S, Hopf U, Marcellin P, Cooksley WG, Fevery J, Diago M, Reddy R, Peters M, Rittweger K, Rakhit A, Pardo M. 2000. A phase I/II study of recombinant human interleukin-12 in patients with chronic hepatitis B. J Hepatol 32:317-324.
8. Cavanaugh VJ, Guidotti LG, Chisari FV. 1997. Interleukin-12 inhibits hepatitis B virus replication in transgenic mice. J Virol 71:3236-3243.
9. Chan HL, Leung NW, Lau TC, Wong ML, Sung JJ. 2000. Comparison of three different sensitive assays for hepatitis B virus DNA in monitoring of responses to antiviral therapy. J Clin Microbiol 38:3205-3208.
10. Chang JT, Segal BM, Nakanishi K, Okamura H, Shevach EM. 2000. The costimulatory effect of IL-18 on the induction of antigen-specific IFN-gamma production by resting T cells is IL-12 dependent and is mediated by up-regulation of the IL-12 receptor beta2 subunit. Eur J Immunol 30:1113-1119.
11. Chisari FV, Ferrari C. 1995. Hepatitis B virus immunopathogenesis. Annu Rev Immunol 13:29-60.
12. Chomczynski P, Sacchi N. 1987. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Ann Biochem 162:156-159.
13. Crowther RA, Kiselev NA, Bottcher B, Berriman JA, Borisova GP, Ose V, Pumpen P. 1994. Three-dimensional structure of hepatitis B virus core particles determined by electron cryomicroscopy. Cell 77:943-950.
14. Diepolder HM, Ries G, Jung MC, Schlicht HJ, Gerlach JT, Grner N, Caselmann WH, Pape GR. 1999. Differential antigen-processing pathways of the hepatitis B virus e and core proteins. Gastroenterology 116:650-657.
15. Fujioka N, Akazawa R, Ohashi K, Fujii M, Ikeda M, Kurimoto M. 1999. Interleukin-18 protects mice against acute herpes simplex virus type 1 infection. J Virol 73:2401-2409.
16. Fukuda R, Ishimura N, Nguyen TX, Chowdhury A, Ishihara S, Kohge N, Akagi S, Watanabe M, Fukumoto S. 1995. The expression of IL-2, IL-4 and interferon-gamma (IFN-gamma) mRNA using liver biopsies at different phases of acute exacerbation of chronic hepatitis B. Clin Exp Immunol 100:446-451.
17. Ghayur T, Banerjee S, Hugunin M, Butler D, Herzog L, Carter A, Quintal L, Sekut L, Talanian R, Paskind M, Wong W, Kamen R, Tracey D, Allen H. 1997. Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production. Nature 386:619-623.
18. Hanck C, Glatzel M, Singer MV, Rossol S. 2000. Gene expression of TNF-receptors in peripheral blood mononuclear cells of patients with alcoholic cirrhosis. J Hepatol 32:51-57.
19. Helmby H, Grencis RK. 2002. IL-18 regulates intestinal mastocytosis and Th2 cytokine production independently of IFN-gamma during Trichinella spiralis infection. J Immunol 169:2553-2560.
20. Ho SK, Chan TM, Cheng IK, Lai KN. 1999. Comparison of the second-generation digene hybrid capture assay with the branched-DNA assay for measurement of hepatitis B virus DNA in serum. J Clin Microbiol 37:2461-2465.
21. Kimura K, Kakimi K, Wieland S, Guidotti LG, Chisari FV. 2002. Interleukin-18 inhibits hepatitis B virus replication in the livers of transgenic mice. J Virol 76:10702-10707.
22. Lazdina U, Cao T, Steinbergs J, Alheim M, Pumpen P, Peterson DL, Milich DR, Leroux-Roels G, Sallberg M. 2001. Molecular basis for the interaction of the hepatitis B virus core antigen with the surface immunoglobulin receptor on naive B cells. J Virol 75:6367-6374.
23. Livingston BD, Alexander J, Crimi C, Oseroff C, Celis E, Daly K, Guidotti LG, Chisari FV, Fikes J, Chesnut RW, Sette A. 1999. Altered helper T lymphocyte function associated with chronic hepatitis B virus infection and its role in response to therapeutic vaccination in humans. J Immunol 162:3088-3095.
24. Manigold T, Bocker U, Traber P, Dong-Si T, Kurimoto M, Hanck C, Singer MV, Rossol S. 2000. Lipopolysaccharide/endotoxin induces IL-18 via CD14 in human peripheral blood mononuclear cells in vitro. Cytokine 12:1788-1792.
25. Messageot F, Carlier D, Rossignol JM. 1998. The C terminus of the hepatitis B virus e antigen precursor is required for a tunicamycin-sensitive step that promotes efficient secretion of the antigen. J Biol Chem 273:18594-18598.
26. Milich DR, McLachlan A. 1986. The nucleocapsid of hepatitis B virus is both a T cell-independent and T cell-dependent antigen. Science 234:1398-1401.
27. Milich DR, McLachlan A, Thorton GB, Hughes JL. 1987. Antibody production to the nucleocapsid and envelope of the hepatitis B virus primed by a single synthetic T cell site. Nature 329:547-549.
28. Milich DR, Schodel F, Hughes JL, Jones JE, Peterson DL. 1997. The hepatitis B virus core and e antigens elicit different Th cell subsets: antigen structure can affect Th cell phenotype. J Virol 71:2192-2201.
29. Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H. 2001. Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol 19:423-474.
30. Okamura H, Tsutsi H, Komatsu T, Yutsudo M, Hakura A, Tanimoto T, Torigoe K, Okura T, Nukada Y, Hattori K, et al. 1995. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 378:88-91.
31. Pirhonen J, Sareneva T, Kurimoto M, Julkunen I, Matikainen S. 1999. Virus infection activates IL-1 beta and IL-18 production in human macrophages by a caspase-1-dependent pathway. J Immunol 162:7322-7329.
32. Pumpen PP, Dishler AV, Kozlovskaia TM, Bychko VV, Gren E. 1981. [Cloning of hepatitis B virus DNA in Escherichia coli.] Dokl Akad Nauk SSSR 260:1022-1024.
33. Riedl P, Buschle M, Reimann J, Schirmbeck R. 2002a. Binding immune-stimulating oligonucleotides to cationic peptides from viral core antigen enhances their potency as adjuvants. Eur J Immunol 32:1709-1716.
34. Riedl P, Stober D, Oehninger C, Melber K, Reimann J, Schirmbeck R. 2002b. Priming Th1 immunity to viral core particles is facilitated by trace amounts of RNA bound to its arginine-rich domain. J Immunol 168:4951-4959.
35. Rossol S, Voth R, Laubenstein HP, Muller WE, Schroder HC, Meyer zum Buschenfelde KH, Hess G. 1989. Interferon production in patients infected with HIV-1. J Infect Dis 159:815-821.
36. Rossol S, Marinos G, Carucci P, Singer MV, Williams R, Naoumov NV. 1997. Interleukin-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis B. J Clin Invest 99:3025-3033.
37. Schlaak JF, Tully G, Lohr HF, Gerken G, Meyer zum Buschenfelde KH. 1999. HBV-specific immune defect in chronic hepatitis B (CHB) is correlated with a dysregulation of pro- and anti-inflammatory cytokines. Clin Exp Immunol 115:508-514.
38. Schlicht HJ, Wasenauer G. 1991. The quaternary structure, antigenicity, and aggregational behavior of the secretory core protein of human hepatitis B virus are determined by its signal sequence. J Virol 65:6817-6825.
39. Schodel F, Peterson D, Zheng J, Jones JE, Hughes JL, Milich DR. 1993. Structure of hepatitis B virus core and e-antigen. A single precore amino acid prevents nucleocapsid assembly. J Biol Chem 268:1332-1337.
40. Seki E, Tsutsui H, Nakano H, Tsuji N, Hoshino K, Adachi O, Adachi K, Futatsugi S, Kuida K, Takeuchi O, Okamura H, Fujimoto J, Akira S, Nakanishi K. 2001. Lipopolysaccharide-induced IL-18 secretion from murine Kupffer cells independently of myeloid differentiation factor 88 that is critically involved in induction of production of IL-12 and IL-1beta. J Immunol 166:2651-2657.
41. Tanaka-Kataoka M, Kunikata T, Takayama S, Iwaki K, Ohashi K, Ikeda M, Kurimoto M. 1999. In vivo antiviral effect of interleukin 18 in a mouse model of vaccinia virus infection [In Process Citation]. Cytokine 11:593-599.
42. Taniguchi M, Nagaoka K, Kunikata T, Kayano T, Yamauchi H, Nakamura S, Ikeda M, Orita K, Kurimoto M. 1997. Characterization of anti-human interleukin-18 (IL-18)/interferon-gamma-inducing factor (IGIF) monoclonal antibodies and their application in the measurement of human IL-18 by ELISA. J Immunol Methods 206:107-113.
43. Ushio S, Namba M, Okura T, Hattori K, Nukada Y, Akita K, Tanabe F, Konishi K, Micallef M, Fujii M, Torigoe K, Tanimoto T, Fukuda S, Ikeda M, Okamura H, Kurimoto M. 1996. Cloning of the cDNA for human IFN-gamma-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein. J Immunol 156:4274-4279.
44. Wagner H. 2002. Interactions between bacterial CpG-DNA and TLR9 bridge innate and adaptive immunity. Curr Opin Microbiol 5:62-69.
45. Wasenauer G, Kock J, Schlicht HJ. 1992. A cysteine and a hydrophobic sequence in the noncleaved portion of the pre-C leader peptide determine the biophysical properties of the secretory core protein (HBe protein) of human hepatitis B virus. J Virol 66:5338-5346.
46. Xu D, Chan WL, Leung BP, Hunter D, Schulz K, Carter RW, McInnes IB, Robinson JH, Liew FY. 1998. Selective expression and functions of interleukin 18 receptor on T helper (Th) type 1 but not Th2 cells. J Exp Med 188:1485-1492.
47. Yoshimoto T, Tsutsui H, Tominaga K, Hoshino K, Okamura H, Akira S, Paul WE, Nakanishi K. 1999. IL-18, although antiallergic when administered with IL-12, stimulates IL-4 and histamine release by basophils. Proc Natl Acad Sci USA 96:13962-13966.